What comes as a shock is that 45th US President Donald Trump has now been infected with the coronavirus. The innovative antibody-drug being given to President Donald Trump has been called one of the most promising ways of stopping serious illness from a Covid-19 infection. Its maker, Regeneron Pharmaceuticals Inc., stated that the company agreed to supply a single dose, given through an IV, for Trump at the request of his physician under “compassionate use” provisions, when an experimental medicine is provided on a case-by-case emergency basis, while studies of it continue. The new drug is in late-stage testing and its safety and effectiveness are not yet known.

Ruckus in market after Donald Trump tested COVID19 positive, price of crude oil falls

No treatment has yet proved able to prevent serious illness after a coronavirus infection. Trump was given the experimental drug at the White House on Friday before he was taken to Walter Reed National Military Medical Center, where he’ll be monitored, officials stated. So far, Trump has had only mild symptoms, including fatigue. Several physicians who treat Covid19, including Dr. David Boulware at the University of Minnesota, had considered that doctors might use the antibody-drug, given that this approach has worked against other diseases in the past.

Federal Judge blocks H-1B visa ban issue given by US President Trump

“They’re not going to just sit around and watch to see if he gets sick,” Boulware said. Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help the immune system eliminate it. Vaccines trick the body into thinking there’s an infection so it makes these antibodies. But it can take weeks for them to form after natural infection or a vaccine. The drugs aim to give that protection immediately, by supplying concentrated versions of one or two antibodies that worked best against the coronavirus in lab and animal tests.

Islam causing distress all over the world: France President Emmanuel Macron